课题基金 / 基金详情

Ubiquitin-mediated events in cell fate decisions

Ubiquitin-mediated events in cell fate decisions
泛素介导的细胞命运决定事件
批准号:
MR/M01102X/1
负责人:
Catherine Lindon
金额:
$57.46万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Catherine Lindon的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The most critical decision that a cell takes when it divides is whether to go ahead and divide again as soon as possible (making more cells), or not to divide for now. Errors in making this decision of cell fate cause cancer and other diseases of cell proliferation.Our general objective is to understand the molecular regulation of pathways that control the cell division cycle in human cells. These pathways are essential, during and after cell division, to generate daughter cells with correct chromosome numbers, correct cell architecture and correct control of future division decisions. We have developed techniques that allow us to probe critical events that involve modification of cellular components through a process known as ubiquitination. Our pilot study has shown that many ubiquitin-mediated pathways control events immediately following cell division and are likely to influence or determine the decision to divide again.We propose research that studies ubiquitination of cellular components in cells committed to the two alternative cell fates. This can provide us with a better understanding of cancer. Current cancer treatments that target dividing cells do not distinguish between dividing cancer cells and dividing healthy cells that retain control over their cell fate. Therefore the ability to distinguish dividing cells with different fates would lead to better targeting of future therapies.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
AURKA destruction is decoupled from its activity at mitotic exit but suppresses interphase activity
AURKA 破坏与其有丝分裂出口时的活性脱钩,但抑制间期活性
DOI: 10.1101/850917
发表时间: 2019
期刊:
影响因子: --
作者: [Abdelbaki A]
通讯作者: Abdelbaki A
DOI: 10.3389/fonc.2015.00307
发表时间: 2015
期刊: Frontiers in oncology
影响因子: 4.7
作者: [Lindon C, Grant R, Min M]
通讯作者: Min M
DOI: 10.1101/236612
发表时间: 2017-12
期刊: bioRxiv
影响因子: --
作者: [Rhys Grant;A. Abdelbaki;Alessia Bertoldi;M. P. Gavilán;J. Mansfeld;D. Glover;C. Lindon]
通讯作者: Rhys Grant;A. Abdelbaki;Alessia Bertoldi;M. P. Gavilán;J. Mansfeld;D. Glover;C. Lindon
DOI: 10.1091/mbc.e15-02-0102
发表时间: 2015-12-01
期刊: Molecular biology of the cell
影响因子: 3.3
作者: [Min M, Mevissen TE, De Luca M, Komander D, Lindon C]
通讯作者: Lindon C
6
    Understanding targeted protein degradation for design of optimized therapeutic strategies
    • 批准号:
      BB/X007499/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $56.46万
    • 财政年份:
      2023
    • 负责人:
      Catherine Lindon
    • 依托单位:
    Translating the ubiquitin code in mitotic cells
    • 批准号:
      BB/R004137/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $50.33万
    • 财政年份:
      2018
    • 负责人:
      Catherine Lindon
    • 依托单位:
    国内基金
    海外基金
    PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
    基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
    Tom1L1在胞内体蛋白分选机制中功能的研究
    • 批准号:
      31171289
    • 项目类别:
      面上项目
    • 资助金额:
      56.0万元
    • 批准年份:
      2011
    • 负责人:
      刘宁生
    • 依托单位:
    溶酶体依赖性TRAF2降解的机制
    • 批准号:
      30971501
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2009
    • 负责人:
      李联运
    • 依托单位: